Thomas R. Ulich
Signal active
Chief Scientific Officer
Contact Information
Social
Primary Organization
InVivo Therapeutics
Founded
2005
Employees
1-10
Industry
Biotechnology, Health Care, Medical Device, Therapeutics
Bio
Dr. Ulich previously served as Executive Vice-President of Research and Development of ConjuChem Biotechnologies from 2006 – 2010.
Prior to that, he served as Senior Vice-President of Research and Development for Alnylam Pharmaceuticals from 2003-2004.
Before that he served at Amgen as Vice-President of Preclinical Development from 1993-2001 and as Vice-President of Preclinical Development and Protein Therapeutics from 2001 – 2003.
Dr. Ulich has a BA from Dartmouth College and an MD from UCLA Medical School. He has medical board certification from the American Board of Anatomic Pathology, the American Board of Clinical Pathology, and the American Board of Immunopathology.
Location
Cambridge, Massachusetts, United States, North America
Jobs history
0
N/A
Board and Advisor Roles
0
N/A
Educations
1
Dartmouth College
unknown
Profile Resume
Thomas R. Ulich is the Chief Scientific Officer at InVivo Therapeutics, based in United States, North America. With a background in Biotechnology, Thomas R. Ulich has a rich history of leadership and innovation.Thomas R. Ulich studied unknown unknown at Dartmouth College. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity